CD226
Basic information
Region (hg38): 18:69831158-69961803
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD226 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 3 | 0 |
Variants in CD226
This is a list of pathogenic ClinVar variants found in the CD226 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-69841334-C-T | not specified | Uncertain significance (May 01, 2024) | ||
18-69841349-A-C | Inborn genetic diseases | Uncertain significance (Jan 31, 2023) | ||
18-69841367-C-A | not specified | Uncertain significance (Jul 22, 2022) | ||
18-69864415-T-C | not specified | Uncertain significance (Feb 13, 2024) | ||
18-69864432-T-C | not specified | Uncertain significance (Oct 14, 2023) | ||
18-69867394-C-T | not specified | Likely benign (Apr 25, 2023) | ||
18-69873226-T-A | not specified | Uncertain significance (Mar 17, 2023) | ||
18-69873238-C-T | not specified | Uncertain significance (Apr 06, 2024) | ||
18-69895752-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
18-69895790-G-C | not specified | Uncertain significance (Aug 12, 2021) | ||
18-69895797-C-T | not specified | Likely benign (Aug 12, 2021) | ||
18-69895812-C-T | not specified | Uncertain significance (Jun 01, 2023) | ||
18-69895919-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
18-69895991-T-C | not specified | Uncertain significance (Nov 19, 2022) | ||
18-69946766-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
18-69946773-G-T | not specified | Uncertain significance (Jun 28, 2022) | ||
18-69946859-A-G | not specified | Uncertain significance (Mar 02, 2023) | ||
18-69946968-A-T | not specified | Uncertain significance (Feb 15, 2023) | ||
18-69947025-C-T | not specified | Likely benign (Dec 21, 2022) | ||
18-69947382-C-G | not specified | Uncertain significance (Nov 30, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD226 | protein_coding | protein_coding | ENST00000280200 | 6 | 130646 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0392 | 0.955 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.737 | 159 | 187 | 0.849 | 0.00000987 | 2196 |
Missense in Polyphen | 31 | 51.332 | 0.60391 | 641 | ||
Synonymous | -0.184 | 73 | 71.0 | 1.03 | 0.00000443 | 635 |
Loss of Function | 2.40 | 5 | 15.1 | 0.332 | 6.39e-7 | 182 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000116 | 0.000116 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000529 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000659 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in intercellular adhesion, lymphocyte signaling, cytotoxicity and lymphokine secretion mediated by cytotoxic T-lymphocyte (CTL) and NK cell (PubMed:8673704). Cell surface receptor for NECTIN2. Upon ligand binding, stimulates T- cell proliferation and cytokine production, including that of IL2, IL5, IL10, IL13, and IFNG. Competes with PVRIG for NECTIN2-binding (PubMed:26755705). {ECO:0000269|PubMed:26755705, ECO:0000269|PubMed:8673704}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System
(Consensus)
Recessive Scores
- pRec
- 0.236
Intolerance Scores
- loftool
- 0.469
- rvis_EVS
- 1.13
- rvis_percentile_EVS
- 92.19
Haploinsufficiency Scores
- pHI
- 0.0647
- hipred
- N
- hipred_score
- 0.273
- ghis
- 0.408
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.162
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd226
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; neoplasm;
Gene ontology
- Biological process
- cytokine production;positive regulation of natural killer cell cytokine production;positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;positive regulation of immunoglobulin mediated immune response;cell adhesion;signal transduction;cell recognition;positive regulation of interferon-gamma production;positive regulation of mast cell activation;positive regulation of natural killer cell mediated cytotoxicity;regulation of immune response;positive regulation of T cell receptor signaling pathway;positive regulation of Fc receptor mediated stimulatory signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane;external side of plasma membrane;cell surface;membrane raft
- Molecular function
- integrin binding;protein binding;protein kinase binding;cell adhesion molecule binding